Skip to content Skip to footer
KMJ PHARMA®

Eliminate compliance blind spots of your medicinal products, medical devices, food supplements or cosmetics

Use KMJ pharma® to respond to regulatory changing environment in pharma and medical industry. With extensive experience in the various regulatory areas, the team members have worked under a range of partnership models over many years of active operation.

Our expertise includes various types of regulatory services for medicinal products (small molecules, large molecules), medical devices, cosmetics and food supplements.

our services

what we do

Strategic Support for Compliant Pharma Marketing: Ensuring Success on the Polish Market

One of our business principles is to support compliant marketing activities of the pharma industry in the Polish market by providing them strategic support in the field of development and review of promotional materials and activities (OTC, HCP communication).

Our team members reviewed and approved more than 3000 promotional materials for HCP’s and Patients for Rx, OTC medicinal products, medical devices and food supplements in Poland and European Union. Let us support development compliant and effective marketing campaigns.

Clients
8080+
Projects
808080+
Years on the market
8080
Reviewed promotional materials
80808080+
KMJ PHARMA®

Strategic Pharma Empowerment


Empowering Pharma Marketing by its regulatory compliance and quality

Unlocking the potential of HCP Engagement in the Evidence based Content Delivery
kmj pharma

Prescribers

Payers

Pharmacists

Distributors

Consumers

warsow2
warsow
Expert Support

Your Global Partner in Regulatory Excellence

Planning European expansion? Run a pharmaceutical business in Europe via Poland – start your European adventure with pharma or medical business. We will deal with all ‘business matters’ on your behalf becoming your ‘boots on the EU ground’. We will help you to prepare regulatory strategy and to register your products in Poland.

For over three decades, Poland has remained one of the most attractive directions for the inflow of foreign pharma and medical industry investments. It has a stable economy with an established macroeconomic position and unique cost-effective conditions for running and opening a business, which is confirmed by economic data.